Telomerase in cancer and aging

Area of Science:

• Gerontology
• Oncology
• Molecular Biology

Background:

• Telomeres, the protective caps of chromosomes, shorten with each cell division, acting as a 'mitotic clock' that signals cellular aging (senescence).
• While most normal somatic cells lack telomerase activity, its reactivation in cancer cells allows them to overcome replicative senescence and achieve immortality.
• The accumulation of molecular and cellular events influencing telomere length is critical in aging and cancer progression.

Purpose of the Study:

• To comprehensively review the multifaceted role of telomerase in the context of cancer.
• To explore telomerase's involvement in cancer initiation, advancement, and its potential as a diagnostic marker.
• To discuss the therapeutic implications of targeting telomerase for cancer treatment.

Main Methods:

• Literature review and synthesis of existing research on telomere biology and telomerase function.
• Analysis of studies investigating telomerase activity in various cancer types and normal cells.
• Examination of preclinical and clinical data related to anti-telomerase therapeutic strategies.

Main Results:

• Telomerase reactivation is a hallmark of nearly all human cancers, enabling uncontrolled proliferation.
• Telomere length maintenance by telomerase is crucial for cancer cell immortalization and tumor growth.
• Dysregulation of telomere maintenance pathways is implicated in both aging and carcinogenesis.

Conclusions:

• Telomerase is a critical factor in cancer development and progression, offering a near-universal target for therapeutic intervention.
• Understanding telomere-telomerase dynamics is essential for developing novel anti-cancer strategies.
• Targeting telomerase holds significant promise for future cancer diagnostics and treatments.